Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.
Contrast Agents for Magnetic Resonance Imaging (MRI) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Contrast Agents for Magnetic Resonance Imaging (MRI) market is projected to reach US$ 1949.3 million in 2034, increasing from US$ 1384.9 million in 2022, with the CAGR of 4.9% during the period of 2024 to 2034. Demand from Radiology and Interventional Radiology are the major drivers for the industry.
Global key MRI contrast agents core players include Bayer, Guerbet Group and Bracco Imaging etc. The top 3 companies hold a share about 82%. Asia-Pacific is the largest market with a share about 35%, followed by North America and Europe.
In terms of product, gadoterate meglumine product is the largest segment with a share about 27%. And in terms of applications, the largest application is hospital with a share about 84%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Contrast Agents for Magnetic Resonance Imaging (MRI) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)
Segment by Type
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Radiology
Interventional Radiology
Interventional Cardiology
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Contrast Agents for Magnetic Resonance Imaging (MRI) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Contrast Agents for Magnetic Resonance Imaging (MRI), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Contrast Agents for Magnetic Resonance Imaging (MRI) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Contrast Agents for Magnetic Resonance Imaging (MRI) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Contrast Agents for Magnetic Resonance Imaging (MRI) introduction, etc. Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Contrast Agents for Magnetic Resonance Imaging (MRI) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Contrast Agents for Magnetic Resonance Imaging (MRI) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Contrast Agents for Magnetic Resonance Imaging (MRI) market is projected to reach US$ 1949.3 million in 2034, increasing from US$ 1384.9 million in 2022, with the CAGR of 4.9% during the period of 2024 to 2034. Demand from Radiology and Interventional Radiology are the major drivers for the industry.
Global key MRI contrast agents core players include Bayer, Guerbet Group and Bracco Imaging etc. The top 3 companies hold a share about 82%. Asia-Pacific is the largest market with a share about 35%, followed by North America and Europe.
In terms of product, gadoterate meglumine product is the largest segment with a share about 27%. And in terms of applications, the largest application is hospital with a share about 84%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Contrast Agents for Magnetic Resonance Imaging (MRI) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)
Segment by Type
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Segment by Application
Radiology
Interventional Radiology
Interventional Cardiology
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Contrast Agents for Magnetic Resonance Imaging (MRI) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Contrast Agents for Magnetic Resonance Imaging (MRI), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Contrast Agents for Magnetic Resonance Imaging (MRI) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Contrast Agents for Magnetic Resonance Imaging (MRI) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Contrast Agents for Magnetic Resonance Imaging (MRI) introduction, etc. Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Contrast Agents for Magnetic Resonance Imaging (MRI) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices